Last updated: December 13, 2023
Sponsor: University Hospital, Strasbourg, France
Overall Status: Active - Recruiting
Phase
N/A
Condition
Osteoarthritis
Bone Diseases
Bone Neoplasm
Treatment
N/AClinical Study ID
NCT05666284
8720
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion criteria:
- Male or female (age ≥18 years old)
- Subject operated for first-line THA for an indication of centric hip osteoarthritis (including minor dysplasia and coxa profunda) and aseptic osteonecrosis of the femoralhead
- Subject who received a THA between January 2015 and December 2019
- Subject who received an uncemented shortened SCC or SCLA femoral stem
- Radiological data available: pre-operative, immediate post-operative andpost-operative at a minimum of 2 years (≥24 months)
- Subject not objecting to the reuse of their data for scientific research purposes.
Exclusion
Exclusion criteria:
- Subject having expressed its opposition to the reuse of its data for scientificresearch purposes.
- Patient operated for inflammatory pathology or major dysplasia, recovery
- Associated fractures or sequelae of fractures
- Patient having presented intraoperative or early complications such as infections,intraoperative fracture, dislocation of the hip following the installation of the THA
- Revision of hip arthroplasty during the study follow-up period for a cause not studiedin the study.
Study Design
Total Participants: 204
Study Start date:
October 11, 2022
Estimated Completion Date:
December 31, 2023
Study Description
Connect with a study center
Service de Chirurgie Orthopédique et de Traumatologie du Membre Inférieur - CHU de Strasbourg - France
Strasbourg, 67091
FranceActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.